Search Results - "Small, Isabele A"

Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2 by ZUKIN, Mauro, BARRIOS, Carlos H, DA ROCHA BALDOTTO, Clarissa Serodio, METON VIEIRA, Fernando, SMALL, Isabele A, FERREIRA, Carlos G, LILENBAUM, Rogerio C, PEREIRA, Jose Rodrigues, DE ALBUQUERQUE RIBEIRO, Ronaldo, DE MENDONCA BEATO, Carlos Augusto, DO NASCIMENTO, Yeni Neron, MURAD, Andre, FRANKE, Fabio A, PRECIVALE, Maristela, DE LIMA ARAUJO, Luiz Henrique

“…To compare single-agent pemetrexed (P) versus the combination of carboplatin and pemetrexed (CP) in first-line therapy for patients with advanced…”
Get full text

Mitomycin-C– or Cisplatin-Based Chemoradiotherapy for Anal Canal Carcinoma: Long-Term Results by Olivatto, Luis O., M.Sc, Cabral, Vânia, M.D, Rosa, Arthur, M.D, Bezerra, Marcos, M.D, Santarem, Erick, M.D, Fassizoli, Ana, M.D, Castro, Leonaldson, Ph.D, Simões, José Humberto, M.S, Small, Isabele A., M.S, Ferreira, Carlos Gil, Ph.D

“…Purpose To evaluate the long-term efficacy of concurrent radiotherapy with mitomycin-C (MMC)–based or cisplatin (CP)-based combinations in a cohort of patients…”
Get full text

Influence of Sentinel Lymph Node Tumor Burden on Survival in Melanoma by Francischetto, Thiago, Spector, Nelson, Neto Rezende, Jose Francisco, de Azevedo Antunes, Marcelle, de Oliveira Romano, Sergio, Small, Isabele A., Gil Ferreira, Carlos

“…Background Completion lymph node dissection (CLND) is the standard procedure for patients with positive sentinel lymph nodes (SLN). With extensive pathological…”
Get full text

Phase I Trial of Erlotinib Combined with Cisplatin and Radiotherapy for Patients with Locally Advanced Cervical Squamous Cell Cancer by NOGUEIRA-RODRIGUES, Angélica, DO CARMO, Claudio C, SMALL, Isabele A, FERREIRA, Carlos G, VIEGAS, Célia, ERLICH, Felipe, CAMISAO, Claudia, FONTAO, Karina, LIMA, Roberta, HERCHENHORN, Daniel, MARTINS, Renato G, MORALEZ, Giulliana M

“…Purpose: This phase I trial was aimed to determine the maximum tolerated dose and related toxicity of erlotinib (E) when administered concurrently with…”
Get full text

Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis by Antunes, Héliton S, Herchenhorn, Daniel, Small, Isabele A, Araújo, Carlos M.M, Viégas, Celia Maria Pais, de Assis Ramos, Gabriela, Dias, Fernando L, Ferreira, Carlos G

“…Highlights • We investigate the impact of low-level laser therapy on the OS, DFS, PFS. • We report data suggesting that morbidity was lower in the Laser Group…”
Get full text

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer by Nogueira‐Rodrigues, Angelica, Moralez, Giulliana, Grazziotin, Rachele, Carmo, Claudio C., Small, Isabele A., Alves, Flavia V.G., Mamede, Marcelo, Erlich, Felipe, Viegas, Celia, Triginelli, Sergio A., Ferreira, Carlos G.

“…BACKGROUND Cisplatin‐based chemoradiation (CRT) is the standard treatment for patients with locally advanced cervical cancer. Epidermal growth factor receptor…”
Get full text

Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial by Bines, José, Small, Isabele A, Sarmento, Roberta, Kestelman, Fabiola, Silva, Silvania, Rodrigues, Fabiana Resende, Faroni, Lilian, Gonçalves, Aline, Ebecken, Erika, Maroun, Pedro, Millen, Eduardo, Bonamino, Martin

“…Background Taxanes usually follow anthracyclines in breast cancer neo/adjuvant treatment, likely because of their later introduction into clinical practice…”
Get full text

Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation by Antunes, Heliton S, Herchenhorn, Daniel, Small, Isabele A, Araújo, Carlos M.M, Viégas, Celia Maria Pais, Cabral, Elida, Rampini, Mariana P, Rodrigues, Pedro C, Silva, Tereza G.P, Ferreira, Elza M.S, Dias, Fernando L, Ferreira, Carlos G

“…Abstract Background Oral mucositis (OM) is a complication of chemoradiotherapy treatment of head and neck squamous cell carcinoma (HNSCC) patients with no…”
Get full text

XAF1 mRNA expression improves progression-free and overall survival for patients with advanced bladder cancer treated with neoadjuvant chemotherapy by Pinho, Marcos B., MSc, Costas, Fernanda, B.S, Sellos, João, B.S, Dienstmann, Rodrigo, M.D, Andrade, Patricia B., M.D, Herchenhorn, Daniel, M.D, Peixoto, Fábio Afonso, M.D, Santos, Valdelice O., R.N, Small, Isabele A., MSc, Guimarães, Denise P., M.D., Ph.D, Ferreira, Carlos G., M.D., Ph.D

“…Abstract Purpose The aim of this study was to investigate whether mRNA expression of the apoptosis-associated genes, XAF1 and XIAP, in bladder cancer patients…”
Get full text

Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation by Antunes, Héliton S, Schluckebier, Luciene Fontes, Herchenhorn, Daniel, Small, Isabele A, Araújo, Carlos M.M, Viégas, Celia Maria Pais, Rampini, Mariana P, Ferreira, Elza M.S, Dias, Fernando L, Teich, Vanessa, Teich, Nelson, Ferreira, Carlos G

“…Highlights • We are the first to investigate the impact of LLLT on the cost of treatment those patients. • We report data suggesting that morbidity was lower…”
Get full text

Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma by Herchenhorn, Daniel, Dienstmann, Rodrigo, Peixoto, Fabio A, de Campos, Franz S, Santos, Valdelice O, Moreira, Denise M, Cardoso, Hedilene, Small, Isabele A, Ferreira, Carlos G

“…Gemcitabine and cisplatin (GC) is an active combination in the treatment of metastatic bladder cancer. We have prospectively analyzed the efficacy and…”
Get full text

Interferon‐inducible guanylate binding protein (GBP)‐2: A novel p53‐regulated tumor marker in esophageal squamous cell carcinomas by Guimarães, Denise P., Oliveira, Ivanir M., de Moraes, Emanuela, Paiva, Geisilene R., Souza, Daniel M., Barnas, Christoph, Olmedo, Daniele B., Pinto, Carlos E., Faria, Paulo A., De Moura Gallo, Claudia Vitoria, Small, Isabele A., Ferreira, Carlos G., Hainaut, Pierre

“…TP53 mutations are common in esophageal squamous cell carcinomas (SCC). To identify biological markers of possible relevance in esophageal SCC, we (i) searched…”
Get full text

Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation by Herchenhorn, Daniel, Dias, Fernando L, Ferreira, Carlos G, Araújo, Carlos M, Lima, Roberto A, Small, Isabele A, Kligerman, Jacob

“…The combination of chemotherapy and radiotherapy is a standard nonsurgical treatment for locally advanced laryngeal cancer. Nevertheless, there are no…”
Get more information

Phase II Trial of Neoadjuvant Chemotherapy Using Alternating Doublets in Non-Small-Cell Lung Cancer by Martins, Renato G, Dienstmann, Rodrigo, de Biasi, Paulo, Dantas, Karina, Santos, Valdelice, Toscano, Edson, Roriz, Walter, Zamboni, Mauro, Sousa, Aureliano, Small, Isabele A, Moreira, Denise, Ferreira, Carlos G, Zukin, Mauro

“…Abstract Purpose Lung cancer is an epidemic disease in developing countries. Incorporation of new active drugs in the neoadjuvant treatment of operable…”
Get full text

Re: Phase II trial of neoadjuvant gemcitabine and cisplatin in patients with resectable bladder carcinoma by Sherif, Amir

Get full text